These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5314713)

  • 81. [Studies on drug controlled blood distribution as a conservative therapeutic principle in arteriosclerosis obliterans].
    Mörl H; Preuss EG; Bartusch M; Schneider W
    Z Kreislaufforsch; 1972 Feb; 61(2):144-52. PubMed ID: 5026177
    [No Abstract]   [Full Text] [Related]  

  • 82. Assessment of the efficacy of vasodilator drugs in peripheral vascular disease through a study of skeletal muscle metabolism using 31P nuclear magnetic resonance (NMR) spectroscopy.
    Wahl D; Simon JP; Escanye JM; Jouanny P; Robin B; Walker P; Paille F; Schmidt C; Robert J; Schmitt J
    Therapie; 1992; 47(2):125-6. PubMed ID: 1412138
    [No Abstract]   [Full Text] [Related]  

  • 83. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 84. [31P magnetic resonance spectroscopy: a noninvasive method for studying skeletal muscle metabolism in patients with arteriosclerosis obliterans of the vessels of the lower extremities and for assessing the efficacy of vasoprostan therapy].
    Sinitsyn VE; Veselova TN; Bakharev AO; Karpov IuA
    Ter Arkh; 1996; 68(12):69-72. PubMed ID: 9054047
    [No Abstract]   [Full Text] [Related]  

  • 85. Dextran anaphylaxis.
    Maddi VI; Wyso EM; Zinner EN
    Angiology; 1969 May; 20(5):243-8. PubMed ID: 5768784
    [No Abstract]   [Full Text] [Related]  

  • 86. [Progress surveillance of limb artery occlusions].
    Bollinger A; Lüthy E
    Schweiz Med Wochenschr; 1966 Aug; 96(34):1094-8. PubMed ID: 5985858
    [No Abstract]   [Full Text] [Related]  

  • 87. Prevention of experimental atherosclerosis with pyridinolcarbamate.
    Wu CC; Huang TS; Hsu CJ
    Am Heart J; 1969 May; 77(5):657-67. PubMed ID: 5778056
    [No Abstract]   [Full Text] [Related]  

  • 88. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
    Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
    [No Abstract]   [Full Text] [Related]  

  • 89. [Angioprotective activity of mexicor in atherosclerosis obliterans of the lower limbs].
    Inchina VI; Smirnov LD; Romanov MD; Kokoreva EV; Morozov MIu
    Angiol Sosud Khir; 2007; 13(3):17-20. PubMed ID: 18382390
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effect of pyridinolcarbamate on aortic and coronary atherosclerosis in squirrel monkeys (Saimiri sciurea).
    Malinow MR; Perley A; McLaughlin P
    J Atheroscler Res; 1968; 8(3):455-61. PubMed ID: 5660506
    [No Abstract]   [Full Text] [Related]  

  • 91. [ALTERATIONS OF CUTANEOUS AND MUSCULAR SENSITIVITY IN CHRONIC OBLITERATING ARTERIOPATHIES OF THE LOWER LIMBS AND THEIR IMPORTANCE IN THE DETERMINATION OF INTERMITTENT CLAUDICATION].
    ARCANGELI P; CORRADI F; D AYALAVALVA G
    Rass Neurol Veg; 1964 Aug; 18():167-238. PubMed ID: 14204209
    [No Abstract]   [Full Text] [Related]  

  • 92. Atherosclerosis obliterans in healthy young adults.
    Baker MS; Mucci RM; Tovey JD; Baker BH
    Am Surg; 1977 Apr; 43(4):208-10. PubMed ID: 851292
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Therapeutic trials with Ismelin in angio-organopathies].
    Zăgreanu J; Hărăgus S; Uza G; Vlaicu R; Schneider E
    Munch Med Wochenschr; 1969 Feb; 111(8):421-4. PubMed ID: 5818956
    [No Abstract]   [Full Text] [Related]  

  • 94. Prospective study of sarpogrelate hydrochloride on patients with arteriosclerosis obliterans.
    Ren S; Qian S; Wang W; Liu J; Liu P
    Ann Thorac Cardiovasc Surg; 2013; 19(1):30-4. PubMed ID: 23364237
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Buerger's disease (thromboangiitis obliterans): an analysis of the arteriograms of 119 cases.
    Suzuki S; Mine H; Umehara I; Yoshida T; Okada Y
    Clin Radiol; 1982 Mar; 33(2):235-40. PubMed ID: 7067357
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Case of ergot poisoning.
    Yao ST; Goodwin DP; Kenyon JR
    Br Med J; 1970 Jul; 3(5714):86-7. PubMed ID: 5428784
    [No Abstract]   [Full Text] [Related]  

  • 97. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T; Motomiya T; Isokane N; Shimamoto T
    Jpn Heart J; 1971 Jul; 12(4):335-46. PubMed ID: 5314713
    [No Abstract]   [Full Text] [Related]  

  • 98. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T
    Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
    [No Abstract]   [Full Text] [Related]  

  • 99. [A double blind crossover trial in pyridinolcarbamate treatment of atherosclerosis obliterans].
    Yamashita S
    Nihon Naika Gakkai Zasshi; 1969 Apr; 58(4):283-92. PubMed ID: 4896659
    [No Abstract]   [Full Text] [Related]  

  • 100. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
    Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.